share_log

HC Wainwright & Co. Maintains Buy on Astria Therapeutics, Maintains $18 Price Target

HC Wainwright & Co. Maintains Buy on Astria Therapeutics, Maintains $18 Price Target

HC Wainwright & Co.维持对Astria Therapeutics的买入,维持18美元的目标股价
Moomoo 24/7 ·  03/25 12:35

HC Wainwright & Co. analyst Joseph Pantginis maintains Astria Therapeutics (NASDAQ:ATXS) with a Buy and maintains $18 price target.

HC Wainwright & Co. 分析师约瑟夫·潘吉尼斯维持Astria Therapeutics(纳斯达克股票代码:ATXS)的买入并维持18美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发